Koselugo 25 MG capsule UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJK5C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,564
Award facts
- Contract value 100% obligated
- $12,563.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,563.84 to AmerisourceBergen Drug Corp for Koselugo 25 mg capsules (60-count units) on January 28, 2026, with completion expected by February 19, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Koselugo is a specialized pharmaceutical product used in pediatric cancer treatment, reflecting the Defense Logistics Agency's procurement of critical medical supplies for military healthcare systems.
This delivery order is issued under AmerisourceBergen's (now operating as a division of parent company Cencora, Inc.) larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This comprehensive IDC serves as the primary vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. AmerisourceBergen's performance under multiple federal contracts demonstrates its established capability to meet government procurement requirements for essential pharmaceutical commodities across various therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FJK5C?
SPE2DR26FJK5C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FJK5C worth?
The government has obligated $12,564 on SPE2DR26FJK5C.
Is contract SPE2DR26FJK5C an order under another contract?
Yes. SPE2DR26FJK5C is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK5C competed?
The extent of competition for SPE2DR26FJK5C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award